Ellis Investment Partners, LLC Novartis Ag Transaction History

Ellis Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $37,305 - $43,630	-500 Reduced 20.88%	1,895 $144,000
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $135,756 - $158,062	1,686 Added 237.8%	2,395 $202,000
Q1 2022 May 03, 2022	SELL	$80.11 - $90.62 $14,099 - $15,949	-176 Reduced 19.89%	709 $62,000
Q1 2020 Apr 17, 2020	BUY	$70.67 - $99.01 $12,437 - $17,425	176 Added 24.82%	885 $71,000
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $6.15 Million - $7.57 Million	-81,593 Reduced 99.14%	709 $65,000
Q1 2019 Apr 24, 2019	BUY	$75.32 - $86.15 $6.2 Million - $7.09 Million	82,302 New	82,302 $82,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.